Patients with non-valvular atrial fibrillation now have an alternative to long-term warfarin medication therapy.
Deborah® was among the first in the region to implant the newly FDA-approved WATCHMAN™ Left Atrial Appendage Closure (LAAC) Implant. This is a breakthrough for patients with AF who are suitable for warfarin therapy, but who have reason to seek a non-drug alternative.
The WATCHMAN™ Implant closes off the left atrial appendage to keep harmful blood clots within the LAA from entering the bloodstream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin. The implantation is a one-time procedure that usually takes about an hour.
Patients with atrial fibrillation have a five times greater risk of stroke. According to device manufacturer Boston Scientific, many of these patients would benefit from a WATCHMAN™ implant.
After the procedure, patients will stay in the hospital overnight for observation.
Many people with Atrial Fibrillation don’t take important blood thinning medication as prescribed by their doctor, which poses a serious risk to their health. At Deborah, there is an exciting treatment option for A-Fib patients that provides an alternative to long term blood thinners medication: The Watchman procedure. Dr. Ice and Dr. Corbisiero are here to tell you more about it.Watch Video
By participating in this quiz, or screening or health assessment, I recognize and accept all risks associated with it. I understand that the program will only screen for certain risk factors and does not constitute a complete physical exam. For the diagnosis of a medical problem, I must see a physician for a complete medical exam. I release Deborah Heart and Lung Center and any other organization(s) involved in this screening, and their employees and agents, from all liabilities, medical claims or expenses which may arise from my participation. Thank you for investing in your health by participating today.